LeMaitre Vascular Inc (OQ:LMAT)

Business Focus: Advanced Medical Equipment & Technology

Nov 11, 2020 04:34 pm ET
LeMaitre Vascular to Present at the Jefferies Virtual London Healthcare Conference
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at Jefferies Virtual London Healthcare Conference on Wednesday, November 18, 2020, at 12:25 PM ET. LeMaitre Vascular is a provider of devices,...
Nov 04, 2020 09:50 am ET
LeMaitre Vascular to Present at Upcoming Investor Conferences
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in November. David Roberts, President, is scheduled to present at the Stifel Virtual Healthcare Conference on Monday, November 16, 2020,...
Oct 29, 2020 04:05 pm ET
LeMaitre Vascular Announces Q3 2020 Financial Results
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q3 2020 results and announced a $0.095/share quarterly dividend. Q3 2020 Results Sales of $36.4mm, +25% (-3% organic) vs. Q3 2019Op....
Oct 09, 2020 06:18 pm ET
LeMaitre Vascular Will Announce Third Quarter 2020 Earnings Results on October 29, 2020
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2020 financial results on Thursday, October 29, 2020, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to...
Sep 22, 2020 06:30 pm ET
Sidoti Virtual Investor Conference
NEW YORK, NY / ACCESSWIRE / September 22, 2020 / Sidoti & Company, LLC has released the presentation schedule, with weblink click-throughs, for Wednesday, September 23, 2020, the first day of its two-day Fall 2020 Virtual Investor Conference. The presentation schedule and related links for day two of the virtual event, Thursday, September 24, 2020, will be published shortly after the conclusion of Wednesday's session or can be found at www.sidoticonference.com/events (click Schedule).
Aug 31, 2020 03:33 pm ET
LeMaitre Vascular to Present at Upcoming Investor Conferences
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in three investor conferences in September. JJ Pellegrino, Chief Financial Officer, is scheduled to participate in the 13th Annual Barrington Research Virtual Fall...
Jul 29, 2020 12:12 pm ET
LeMaitre Vascular to Present at Upcoming Investor Conferences
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in August. JJ Pellegrino, Chief Financial Officer, is scheduled to present at the virtual Canaccord Genuity 40th Annual Growth...
Jul 23, 2020 04:25 pm ET
LeMaitre Vascular Announces Q2 2020 Financial Results
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2020 results and announced a $0.095/share quarterly dividend. Q2 2020 Results Sales of $24.9mm, -16% (-24% organic) vs. Q2 2019Op....
Jul 10, 2020 03:11 pm ET
LeMaitre Vascular Will Announce Second Quarter 2020 Earnings Results on July 23, 2020
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2020 financial results on Thursday, July 23, 2020, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to...
Jun 22, 2020 04:13 pm ET
LeMaitre Vascular Acquires Artegraft
LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced that it has acquired the business and assets of Artegraft, Inc. for $90.0 million, including $72.5 million in cash paid at closing ($65.0 million to Artegraft plus $7.5 in escrow to be released...
Jun 01, 2020 05:30 am ET
Admedus Changes Name to Anteris Technologies Ltd
Admedus Limited (ASX: AHZ), announced today that it has changed the Company’s name to Anteris Technologies Ltd (“Anteris”). As of May 22, 2020 Anteris, is trading on the Australian Securities Exchange under the ticker AVR. This milestone signifies...
May 28, 2020 05:59 pm ET
LeMaitre Vascular to Present at the Jefferies Virtual Healthcare Conference
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Jefferies Virtual Healthcare Conference on Thursday, June 4, 2020, at 2:00 PM EDT. LeMaitre Vascular is a provider of devices,...
May 12, 2020 10:35 am ET
LeMaitre Vascular to Present at the UBS Virtual Global Healthcare Conference
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the UBS Virtual Global Healthcare Conference on Wednesday, May 20, 2020, at 8:20 AM EDT. LeMaitre Vascular is a provider of devices, implants and...
Apr 30, 2020 04:05 pm ET
LeMaitre Vascular Announces Q1 2020 Financial Results
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2020 results and announced a $0.095/share quarterly dividend. Q1 2020 Results Record sales of $30.6mm, +7% (-1% organic) vs. Q1...
Apr 13, 2020 04:50 pm ET
LeMaitre Vascular Withdraws Prior Annual Guidance for 2020 And Announces Preliminary Q1 2020 Financial Results
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, announced today Q1 2020 preliminary, unaudited results and withdrew prior annual guidance for 2020 due to the potential impact of COVID-19. Q1 2020...
Mar 04, 2020 11:07 am ET
LeMaitre Vascular to Present at Upcoming Investor Conferences
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in three investor conferences in March. David Roberts, President, is scheduled to present at the Barclays Global Healthcare Conference on Thursday, March 12, 2020...
Feb 18, 2020 12:28 pm ET
LeMaitre Vascular to Present at the SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2020
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the 9th Annual SVB Leerink Global Healthcare Conference on Tuesday, February 25, 2020 at the Lotte New York Palace Hotel in New York City. The...
Feb 06, 2020 04:05 pm ET
LeMaitre Vascular Announces Q4 2019 Financial Results
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2019 results, provided guidance, and announced a $0.095/share dividend. Q4 2019 Results Record sales of $30.2mm, +6% (flat organic)...
Jan 29, 2020 02:13 pm ET
LeMaitre Vascular Will Announce Fourth Quarter 2019 Earnings Results on February 6, 2020
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2019 financial results on Thursday, February 6, 2020, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to...
Jan 03, 2020 11:45 am ET
LeMaitre Vascular to Present at the Needham Growth Conference on Wednesday, January 15, 2020
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 22nd Annual Needham Growth Conference on Wednesday, January 15, 2020 at the Lotte New York Palace Hotel in New York City. The...
Nov 15, 2019 06:35 pm ET
LeMaitre Vascular to Present at Upcoming Investor Conferences
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be presenting at two conferences in November. David Roberts, President, is scheduled to present at the 2019 Stifel Healthcare Conference on Wednesday, November 20, 2019 at...
Oct 23, 2019 04:05 pm ET
LeMaitre Vascular Announces Q3 2019 Financial Results
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q3 2019 results, provided guidance, and announced an $0.085/share dividend. Q3 2019 Results Sales of $29.1mm, +20% (+13% organic) vs....
Oct 13, 2019 07:00 pm ET
LeMaitre Vascular Acquires Biologic Patch Business from Admedus
LeMaitre Vascular, Inc. (Nasdaq: LMAT), announced that it has acquired the biologic patch business of Admedus Ltd (ASX: AHZ) for $15.5 million, of which $14.2 million was paid at closing and $1.3 million is due in two post-closing installments, as...
Oct 11, 2019 03:36 pm ET
LeMaitre Vascular Will Announce Third Quarter 2019 Earnings Results on October 23, 2019
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2019 financial results on Wednesday, October 23, 2019, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to...
Aug 26, 2019 09:00 am ET
LeMaitre Vascular to Present at Upcoming Investor Conferences
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be presenting at the Wells Fargo Healthcare Conference, Baird Global Healthcare Conference and the Sidoti & Company Fall Conference in September. JJ Pellegrino, Chief Financial...
Jul 30, 2019 12:29 pm ET
LeMaitre Vascular to Present at the Canaccord Genuity Annual Growth Conference on Thursday, August 8, 2019
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Canaccord Genuity 39th Annual Growth Conference on Thursday, August 8, 2019 at the InterContinental Hotel in Boston, MA. The...
Jul 24, 2019 04:05 pm ET
LeMaitre Vascular Announces Q2 2019 Financial Results
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2019 results, provided guidance, and announced a $0.085/share dividend. Q2 2019 Results Record sales of $29.5mm, +9% (+5% organic) vs....
Jul 11, 2019 05:27 pm ET
LeMaitre Vascular Will Announce Second Quarter 2019 Earnings Results on July 24, 2019
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2019 financial results on Wednesday, July 24, 2019, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to...
May 29, 2019 01:43 pm ET
LeMaitre Vascular to Present at the Jefferies Healthcare Conference on Thursday, June 6, 2019
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Jefferies Healthcare Conference on Thursday, June 6, 2019 at the Grand Hyatt Hotel in New York City. The Company is scheduled to...
May 06, 2019 04:15 pm ET
LeMaitre Vascular to Present at Upcoming Investor Conferences
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in two investor conferences in May. David Roberts, President, is scheduled to attend the Deutsche Bank Healthcare Conference on Tuesday, May 7, 2019 at the...
May 01, 2019 04:05 pm ET
LeMaitre Vascular Announces Q1 2019 Financial Results
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2019 results, provided guidance, and announced a $0.085/share dividend. Q1 2019 Results Record sales of $28.5mm, +10% (+7%...
Apr 24, 2019 04:15 pm ET
LeMaitre Vascular Will Announce First Quarter 2019 Earnings Results on May 1, 2019
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2019 financial results on Wednesday, May 1, 2019, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to...
Mar 08, 2019 02:48 pm ET
LeMaitre Vascular to Present at Upcoming Investor Conferences
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in four investor conferences in March. JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Cowen Annual Healthcare Conference on Monday, March...
Feb 22, 2019 08:30 am ET
LeMaitre Vascular to Present at Upcoming Investor Conferences
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in two conferences in February. David Roberts, President, is scheduled to present at the 8th Annual Leerink Partners Global Healthcare Conference on Wednesday,...
Feb 19, 2019 04:05 pm ET
LeMaitre Vascular Announces Q4 2018 Financial Results
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2018 results, provided guidance, announced a 21% dividend increase to $0.085/share and announced a share repurchase program. Q4 2018...
Feb 06, 2019 04:30 pm ET
LeMaitre Vascular Will Announce Fourth Quarter 2018 Earnings Results on February 19, 2019
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2018 financial results on Tuesday, February 19, 2019, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to...
Jan 08, 2019 05:17 pm ET
LeMaitre Vascular to Present at the Needham Growth Conference on Wednesday, January 16, 2019
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at Needham Growth Conference on Wednesday, January 16, 2019 at the Lotte New York Palace Hotel in New York, NY. The Company is...
Nov 16, 2018 07:30 am ET
Report: Exploring Fundamental Drivers Behind HC2, Pangaea Logistics Solutions, Sophiris Bio, Acacia Research, JAKKS Pacific, and LeMaitre Vascular — New Horizons, Emerging Trends, and Upcoming Develop
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of HC2 Holdings, Inc. (NYSE:HCHC), Pangaea Logistics Solutions Ltd....
Nov 09, 2018 03:45 pm ET
LeMaitre Vascular to Present at Upcoming Investor Conferences
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be presenting at four conferences in November. David Roberts, President, is scheduled to present at the Stifel Healthcare Conference on Tuesday, November 13, 2018 at the Lotte New...
Oct 24, 2018 04:50 pm ET
LeMaitre Vascular Acquires Cardial Business of BD
LeMaitre Vascular, Inc. (Nasdaq:LMAT), announced today that it has acquired the assets of Cardial, a subsidiary of BD (Becton, Dickinson Company), located in Saint-Étienne, France. The total purchase price for the acquired assets was €2.0...
Oct 04, 2018 04:48 pm ET
LeMaitre Vascular Announces Preliminary Q3 2018 Results
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, announced today Q3 2018 preliminary unaudited results, provided Q4 2018 and updated full year 2018 guidance, and announced a $0.07/share dividend. Q3...
Sep 26, 2018 04:16 pm ET
LeMaitre Vascular Acquires Clot Management Business from Applied Medical
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it has acquired the vascular clot management business of Applied Medical Resources Corporation for $14.2 million, of which $11.0 million was paid at closing and $3.2 million will be paid in...
Sep 07, 2018 09:15 am ET
LeMaitre Vascular to Present at Upcoming Investor Conferences
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be presenting at four conferences in September. David Roberts, President, will participate in the Lake Street Best Ideas Growth Conference on Thursday, September 13, 2018 at the...
Aug 31, 2018 12:30 pm ET
LeMaitre Vascular to Present at Upcoming Investor Conferences
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be presenting at the Wells Fargo Healthcare and RW Baird Healthcare conferences next week. George LeMaitre, Chairman CEO, is scheduled to present at the Wells Fargo Healthcare...
Aug 01, 2018 04:15 pm ET
LeMaitre Vascular to Present at Upcoming Investor Conferences
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in two conferences in August. JJ Pellegrino, Chief Financial Officer, will participate in the 3rd Annual Needham MedTech One-on-One Conference on Tuesday, August...
Jul 26, 2018 04:05 pm ET
LeMaitre Q2 2018 Record Sales $27.0mm (+5%), Record EPS $0.43 (+86%)
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2018 results, provided guidance and announced a $0.07/share dividend. Q2 2018 Results  Record sales of $27.0mm, +5% vs. Q2 2017Record...
Jul 18, 2018 04:15 pm ET
LeMaitre Vascular Will Announce Second Quarter 2018 Earnings Results on July 26, 2018
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2018 financial results on Thursday, July 26, 2018, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to...
Jun 01, 2018 08:30 am ET
LeMaitre Vascular to Present at the Jefferies Healthcare Conference on Friday, June 8, 2018
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Jefferies Healthcare Conference on Friday, June 8, 2018 at the Grand Hyatt Hotel in New York, NY. The Company is scheduled to...
May 03, 2018 04:15 pm ET
LeMaitre Vascular to Present at Upcoming Investor Conferences
LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be presenting in three conferences in May. David Roberts, President, is scheduled to present at the Deutsche Bank Healthcare Conference on Tuesday, May 8, 2018 at the...
Apr 25, 2018 04:05 pm ET
LeMaitre Q1 2018 Sales $26.0mm (+8%), EPS $0.19 (+17%)
BURLINGTON, Mass., April 25, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2018 results, provided guidance, and announced a $0.07/share dividend.
Apr 18, 2018 04:35 pm ET
LeMaitre Vascular Will Announce First Quarter 2018 Earnings Results on April 25, 2018
BURLINGTON, Mass., April 18, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2018 financial results on Wednesday, April 25, 2018, after the market close. The company has scheduled a conference call...
Apr 05, 2018 04:50 pm ET
LeMaitre Vascular Divests General Surgery Product Lines
BURLINGTON, Mass., April 05, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), announced today that it has divested its general surgery product lines to Symmetry Surgical, Inc. for $7.4 million.
Feb 28, 2018 08:30 am ET
LeMaitre Vascular to Present at Upcoming Investor Conferences
BURLINGTON, Mass., Feb. 28, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in seven investor conferences in March.
Feb 21, 2018 04:06 pm ET
LeMaitre Q4 2017 Record Sales $26.2mm (+12%), Record Op. Income $6.3mm (+62%)
BURLINGTON, Mass., Feb. 21, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2017 results, provided guidance, and announced a 27% dividend increase to $0.07/share.
Feb 21, 2018 01:00 pm ET
LeMaitre Vascular, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 21, 2018 / LeMaitre Vascular, Inc. (NASDAQ: LMAT) will be discussing their earnings results in their Q4 Earnings Call to be held on February 21, 2018 at 5:00 PM Eastern Time.
Feb 09, 2018 08:00 am ET
LeMaitre Vascular Will Announce Fourth Quarter 2017 Earnings Results on February 21, 2018
BURLINGTON, Mass., Feb. 09, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2017 financial results on Wednesday, February 21, 2018, after the market close. The company has scheduled a conference call...
Jan 11, 2018 04:15 pm ET
LeMaitre Vascular to Present at the Needham Growth Conference on Thursday, January 18, 2018
BURLINGTON, Mass., Jan. 11, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at Needham & Company’s 20th Annual Growth Conference on Thursday, January 18, 2018 at the Lotte...
Nov 01, 2017 04:30 pm ET
LeMaitre Vascular to Present at Upcoming November and December Investor Conferences
BURLINGTON, Mass., Nov. 01, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in six investor conferences in November and December....
Nov 01, 2017 04:30 pm ET
LeMaitre Vascular to Present at Upcoming November and December Investor Conferences
BURLINGTON, Mass., Nov. 01, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in six investor conferences in November and December.
Oct 26, 2017 04:05 pm ET
LeMaitre Q3 2017 Sales $24.8mm (+7%), Record EPS $0.25 (+49%)
BURLINGTON, Mass., Oct. 26, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q3 2017 results, provided guidance, and announced a $0.055/share dividend....
Sep 05, 2017 04:05 pm ET
LeMaitre Vascular to Present at Upcoming Investor Conferences
BURLINGTON, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in three investor conferences....
Aug 01, 2017 04:15 pm ET
LeMaitre Vascular to Present at Upcoming Investor Conferences
BURLINGTON, Mass., Aug. 01, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in two investor conferences....
Jul 27, 2017 04:05 pm ET
LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%)
BURLINGTON, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2017 results, provided increased guidance, announced a $0.055/share dividend and authorized a $7.5mm share repurchase program....
Jul 13, 2017 04:15 pm ET
LeMaitre Vascular Will Announce Second Quarter 2017 Earnings Results on July 27, 2017
BURLINGTON, Mass., July 13, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2017 financial results on Thursday, July 27, 2017, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook....
May 01, 2017 07:08 pm ET
LeMaitre Vascular Set to Join S&P SmallCap 600
NEW YORK, May 1, 2017 /PRNewswire/ -- LeMaitre Vascular Inc. (NASD: LMAT) will replace First NBC Bank Holding Co. (NASD: FNBC) in the S&P SmallCap 600 effective prior to the open on Wednesday, May 3. First NBC Bank was placed into receivership today and is therefore no longer eligible for continued inclusion in the S&P SmallCap 600....
Apr 26, 2017 04:05 pm ET
LeMaitre Q1 2017 Record Sales $24.1 mm (+19%), Net Income $3.2 mm (+49%)
BURLINGTON, Mass., April 26, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2017 results, provided guidance, and announced a $0.055/share dividend....
Apr 12, 2017 04:15 pm ET
LeMaitre Vascular Will Announce First Quarter 2017 Earnings Results on April 26, 2017
BURLINGTON, Mass., April 12, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its first quarter 2017 financial results on Wednesday, April 26, 2017, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook....
Mar 23, 2017 04:15 pm ET
LeMaitre Vascular to Present at the Sidoti & Company Spring 2017 Convention on Wednesday, March 29, 2017
BURLINGTON, Mass., March 23, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at Sidoti & Company Spring 2017 Convention on Wednesday, March 29, 2017 at the Marriott Marquis, New York City, NY....
Mar 09, 2017 04:05 pm ET
LeMaitre Vascular to Present at the Barclays Global Healthcare Conference on Tuesday, March 14, 2017
BURLINGTON, Mass., March 09, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at Barclays Global Healthcare Conference on Tuesday, March 14, 2017 at the Loews Miami Beach Hotel in Miami Beach, FL....
Mar 08, 2017 04:05 pm ET
LeMaitre Vascular to Present at the 29th Annual ROTH Conference on Tuesday, March 14, 2017
BURLINGTON, Mass., March 08, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that George W. LeMaitre, Chairman & CEO, will present at 29th Annual ROTH Conference on Tuesday, March 14, 2017 at the Ritz-Carlton, Laguna Niguel, CA....
Mar 01, 2017 04:20 pm ET
LeMaitre Vascular to Present at the Cowen & Company 37th Annual Health Care Conference on March 6, 2017
BURLINGTON, Mass., March 01, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Cowen & Company Annual Health Care Conference on Monday, March 6, 2017 at the Marriott Copley Place in Boston, MA....
Feb 23, 2017 04:15 pm ET
LeMaitre Vascular to Participate in 2017 BTIG Medical Technology, Life Science and Diagnostic Tools Conference on Wednesday, March 1, 2017
BURLINGTON, Mass., Feb. 23, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will participate in BTIG’s 2017 Medical Technology, Life Science and Diagnostic Tools Conference on Wednesday, March 1, 2017 in Snowbird, UT....
Feb 21, 2017 04:05 pm ET
LeMaitre Q4 2016 Record Sales $23.3 mm (+14%), Op. Income $3.9 mm (+27%)
BURLINGTON, Mass., Feb. 21, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2016 results, provided guidance, and announced a 22% dividend increase to $0.055/share....
Feb 07, 2017 04:15 pm ET
LeMaitre Vascular Will Announce Fourth Quarter 2016 Earnings Results on February 21, 2017
BURLINGTON, Mass., Feb. 07, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2016 financial results on Tuesday, February 21, 2017, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and company outlook....
Feb 06, 2017 08:30 am ET
LeMaitre Vascular, Inc. Presentation Now Available for On-Demand Viewing
Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation...
Feb 06, 2017 08:30 am ET
LeMaitre Vascular, Inc. Presentation Now Available for On-Demand Viewing
Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation...
Jan 31, 2017 04:01 pm ET
LeMaitre Vascular, Inc. to Webcast, Live, at VirtualInvestorConferences.com February 2
Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual VirtualInvestorConferences.com...
Jan 31, 2017 04:01 pm ET
LeMaitre Vascular, Inc. to Webcast, Live, at VirtualInvestorConferences.com February 2
Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual VirtualInvestorConferences.com...
Jan 30, 2017 02:16 pm ET
Life Sciences & Healthcare Investor Conference & Webinar: Nasdaq and OTCQX Companies Present February 2nd
 CEOs & CFOs share vision, answer questions live at VirtualInvestorsConferences.com ...
Jan 30, 2017 02:16 pm ET
Life Sciences & Healthcare Investor Conference & Webinar: Nasdaq and OTCQX Companies Present February 2nd
 CEOs & CFOs share vision, answer questions live at VirtualInvestorsConferences.com ...
Jan 05, 2017 04:15 pm ET
LeMaitre Vascular to Present at the Needham Growth Conference on Thursday, January 12, 2017
BURLINGTON, Mass., Jan. 05, 2017 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at Needham & Company’s 19th Annual Growth Conference on Thursday, January 12, 2017 at the Lotte New York Palace Hotel in New York, NY....
Dec 07, 2016 04:05 pm ET
LeMaitre Vascular to Participate in the Guggenheim Securities 4th Annual Boston Healthcare Conference on Tuesday, December 13, 2016
BURLINGTON, Mass., Dec. 07, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will participate in the Guggenheim Securities 4th Annual Boston Healthcare Conference on Tuesday, December 13, 2016 at the Intercontinental Hotel in Boston, MA....
Nov 29, 2016 01:30 pm ET
LeMaitre Vascular to Participate in the Benchmark Micro Cap Discovery Conference on Thursday, December 1, 2016
BURLINGTON, Mass., Nov. 29, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will participate in the Benchmark Company Micro Cap Discovery One-on-One Investor Conference on Thursday, December 1, 2016 at the Palmer House Hilton in Chicago, IL....
Nov 08, 2016 04:15 pm ET
LeMaitre Vascular to Present at Three Investor Conferences in November
BURLINGTON, Mass., Nov. 08, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in three investor conferences in November....
Oct 26, 2016 04:05 pm ET
LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%)
BURLINGTON, Mass., Oct. 26, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, today reported Q3 2016 results, provided increased guidance, and announced a $0.045/share dividend....
Oct 25, 2016 03:19 pm ET
LeMaitre Vascular to Present at the Sidoti & Company Fall 2016 Emerging Growth Convention on November 1, 2016
BURLINGTON, Mass., Oct. 25, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Sidoti & Company Fall 2016 Emerging Growth Convention on Tuesday, November 1, 2016 at the New York Marriott Marquis in New York, NY....
Oct 18, 2016 04:08 pm ET
LeMaitre Vascular Will Announce Third Quarter 2016 Earnings Results on October 26, 2016
BURLINGTON, Mass., Oct. 18, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2016 financial results on Wednesday, October 26, 2016, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook....
Sep 20, 2016 03:02 pm ET
LeMaitre Vascular to Participate in the Dougherty & Co. Institutional Investor Conference on September 28, 2016
BURLINGTON, Mass., Sept. 20, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will participate in the 2016 Dougherty & Co. Institutional Investor Conference on Wednesday, September 28, 2016 at the Millennium Hotel in Minneapolis, MN....
Aug 25, 2016 05:43 pm ET
LeMaitre Vascular to Attend the 9th Annual Barrington Research Fall Investment Conference on September 8, 2016
BURLINGTON, Mass., Aug. 25, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the 9th Annual Barrington Research Fall Investment Conference on Thursday, September 8, 2016 at the Four Seasons Hotel in Chicago, IL....
Aug 16, 2016 04:32 pm ET
LeMaitre Vascular to Participate in the Midwest IDEAS Investor Conference on August 30, 2016
BURLINGTON, Mass., Aug. 16, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that George W. LeMaitre, Chairman & CEO, will present at the Midwest IDEAS Investor Conference on Tuesday, August 30, 2016 at the Hard Rock Hotel in Chicago, IL....
Aug 02, 2016 04:26 pm ET
LeMaitre Vascular to Participate in the Canaccord Genuity 36th Annual Growth Conference on August 11, 2016
BURLINGTON, Mass., Aug. 02, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that J.J. Pellegrino, Chief Financial Officer, will present at the Canaccord Genuity 36th Annual Growth Conference on Thursday, August 11, 2016 at the Intercontinental Hotel in Boston, MA....
Jul 27, 2016 04:05 pm ET
LeMaitre Q2 2016 Record Sales $22.4mm (+13%), Record Op. Income $3.8mm (+35%)
BURLINGTON, Mass., July 27, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, today reported Q2 2016 results, provided increased guidance, announced a $0.045/share dividend and authorized a $5.0mm share repurchase program....
Jul 19, 2016 03:36 pm ET
LeMaitre Vascular Will Announce Second Quarter 2016 Earnings Results on July 27, 2016
BURLINGTON, Mass., July 19, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2016 financial results on Wednesday, July 27, 2016, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook....
Jun 16, 2016 04:07 pm ET
LeMaitre Vascular to Present at the East Coast IDEAS Investor Conference on June 28, 2016
BURLINGTON, Mass., June 16, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President will present at the East Coast IDEAS Investor Conference on Tuesday, June 28, 2016 at the Boston Park Plaza in Boston, MA....
May 18, 2016 03:26 pm ET
LeMaitre Vascular to Participate in the Benchmark One-on-One Conference on June 2, 2016
BURLINGTON, Mass., May 18, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will participate in the Benchmark Company, LLC, One-on-One Investor Conference on Thursday, June 2, 2016 at the Pfister Hotel in Milwaukee, WI....
May 05, 2016 04:05 pm ET
John A. Roush Joins the Advanced Energy Board of Directors
FORT COLLINS, Colo., May 05, 2016 (GLOBE NEWSWIRE) -- Advanced Energy Industries, Inc. (Nasdaq:AEIS) today announced that John A. Roush, the chief executive officer of GSI Group, Inc. (Nasdaq:GSIG), a leading global supplier of precision photonic components and subsystems to OEM's in the medical and advanced industrial markets, has joined the company’s board of directors....
May 02, 2016 04:05 pm ET
LeMaitre Q1 2016 Sales $20.3mm (+7%), Op. Inc. $3.3mm (+43%)
BURLINGTON, Mass., May 02, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, today reported Q1 2016 results, announced a $0.045/share dividend and provided guidance....
Mar 18, 2016 03:36 pm ET
CryoLife Announces Sale of ProCol® Distribution Rights and Purchase Option to LeMaitre Vascular, Inc.
ATLANTA, March 18, 2016 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that LeMaitre Vascular, Inc. (Nasdaq: LMAT) has acquired CryoLife's ProCol Vascular Bioprosthesis ("ProCol") distribution rights and purchase option and has exercised that option to acquire ProCol from Hancock Jaffe Laboratories Inc. ("Hancock Jaffe")....

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.